Vaccination with the Omicron spike RBD boosts broadly neutralizing antibody levels and confers sustained protection even after acquiring immunity to the original antigen
International Immunology · 2023
DOI: 10.1093/intimm/dxac055 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2023. Verfasst von Hitoshi Azuma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
The immune evasion of SARS-CoV-2 Omicron variants caused by multiple amino acid replacements in the receptor-binding domain (RBD) of the spike protein wanes the effectiveness of antibodies elicited by current SARS-CoV-2 booster vaccination. The vaccines that target Omicron strains have been recently developed, however, there has been a concern yet to be addressed regarding the negative aspect of the immune response known as original antigenic sin. Here, we demonstrate that the breadth of neutralizing antibodies against SARS-CoV-2 variants is barely elicited by immunizing monovalent viral antigens via vaccination or natural infection in mice and human subjects. However, vaccination of Omicron BA.1 RBD to pre-immunized mice with the original RBD conferred sustained neutralizing activity to BA.1 and BA.2 not only original pseudoviruses. The acquisition of neutralizing antibody breadth was further confirmed in vaccinated-then-Omicron convalescent human sera in which neutralizing activity against BA.1 and BA.2 pseudoviruses was highly induced. Thus, our data suggest that Omicron-specific vaccines or the infection with Omicron viruses can boost potent neutralizing antibodies to the Omicron variants even in the host pre-vaccinated with the original antigen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology.
- Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Azuma, H., Kawano, Y., Shitaoka, K., Kawahara, T., Ito, A., Higashiura, A., Kitajima, Y., Ohki, S., & Yasuda, T. (2023). Vaccination with the Omicron spike RBD boosts broadly neutralizing antibody levels and confers sustained protection even after acquiring immunity to the original antigen. International Immunology. https://doi.org/10.1093/intimm/dxac055
Vancouver
Azuma H, Kawano Y, Shitaoka K, Kawahara T, Ito A, Higashiura A, et al. Vaccination with the Omicron spike RBD boosts broadly neutralizing antibody levels and confers sustained protection even after acquiring immunity to the original antigen. International Immunology. 2023. doi:10.1093/intimm/dxac055
BibTeX
@article{Azuma2023,
author = {Azuma, Hitoshi and Kawano, Yohei and Shitaoka, Kiyomi and Kawahara, Takahiro and Ito, Ayano and Higashiura, Akifumi and Kitajima, Yasuo and Ohki, Shun and Yasuda, Tomoharu},
title = {Vaccination with the Omicron spike RBD boosts broadly neutralizing antibody levels and confers sustained protection even after acquiring immunity to the original antigen},
journal = {International Immunology},
year = {2023},
doi = {10.1093/intimm/dxac055}
}
EUVIMED